Healthcare -
Biotechnology - NASDAQ - US
$ 1.38
-3.5 %
$ 3.82 M
Market Cap
-0.1
P/E
PALI - STOCK-BASED COMPENSATION
Stock-based Compensation PALI - Palisade Bio, Inc.
624 K
LAST VALUE
-42.56%
2 YEAR CAGR
-10.56%
5 YEAR CAGR
-12.35%
10 YEAR CAGR